Stemcell and Regenerative Medicine
Terms and conditions
February 26, 2025   09:00 AM GMT

International Webinar onStemcell and Regenerative Medicine

Early Bird Registration End Date: Jan 31, 2025
Abstract Submission Opens: Dec 02, 2024

Terms and Conditions

Thank you for your interest in our Sciconx webinar. Please carefully review the following terms and conditions regarding registration, refunds, and other important details:

  • Registration for the Sciconx webinar is mandatory for participation.
  • By registering, you agree to adhere to the terms and conditions outlined herein.
  • Payment of the registration fee is required to secure your spot.
  • Access to the Sciconx webinar will be granted upon confirmation of complete payment.

All Registrations fee are non-refundable.

  • If the Sciconx webinar is canceled due to unforeseen circumstances, registrants will not receive a refund.
  • Registrants can attend the next webinar without any registration fee.
  • The organizers reserve the right to cancel the Sciconx webinar and will notify registered participants in a timely manner.
  • Access to the Sciconx webinar will be provided via the specified platform or link, which will be communicated to registered participants in advance.
  • Participants are responsible for ensuring they have the necessary equipment and internet connection for a smooth Sciconx webinar experience.

Substitutions of registered participants for the Sciconx webinar can be made with written notification to the provided email address at least 24 hours before the webinar.

  • The content presented in the Sciconx webinar is for informational purposes only.
  • The organizers are not responsible for the opinions expressed by speakers or presenters.
  • Vaccum deposition and vapourisation
  • The Sciconx webinar may be recorded for future reference and distribution.
  • Attendees' participation in discussions or Q&A sessions may be included in the recording.

The organizers are not responsible for technical issues experienced by participants during the Sciconx webinar, including but not limited to internet connectivity problems.

Participants are expected to adhere to appropriate webinar etiquette, including respectful behavior during discussions and Q&A sessions.

Personal information collected during registration for the Sciconx webinar will be treated in accordance with our privacy policy.

The organizers reserve the right to modify these terms and conditions for Sciconx webinars. Any changes will be communicated to registered participants.

By registering for the Sciconx webinar, you acknowledge and accept these terms and conditions. If you have any questions or concerns, please contact us at the provided email address. We look forward to your participation in the Sciconx webinar.

Latest News

The Alarm's Mike Peters Seeks Stem Cell Donor Amid Health Battle

2024-12-19 - 2024-12

Content: Mike Peters, lead singer of the rock band The Alarm, is urgently searching for a stem cell donor after being diagnosed with Richter's syndrome, a transformation of chronic lymphocytic leukemia into an aggressive lymphoma. Peters has launched the "One in a Million" campaign through the Love Hope Strength foundation to find a matching donor. Despite his health challenges, Peters remains hopeful and continues to engage with his music, recently releasing a new music video.

Mesoblast's Stem Cell Therapy Approved for Pediatric GVHD

2024-12-20 - 2024-12

Biotech company Mesoblast has received FDA approval for Ryoncil, the first treatment for children with acute graft versus host disease (GVHD) unresponsive to steroids. This approval marks a significant advancement in cell therapy, offering a new treatment option for a condition affecting many bone-marrow transplant patients.

U.S. Stem Cell Therapy Market Revenue to Attain USD 17.70 Bn by 2033

2024-12-26 - 2024-12

U.S. Stem Cell Therapy Market Revenue and Trends 2023 to 2033
The U.S. stem cell therapy market revenue surpassed USD 5.99 billion in 2024 and is predicted to attain around USD 17.70 billion by 2033, growing at a CAGR of 12.79%. The rising prevalence of chronic diseases and innovations in stem cell-based therapies drive the growth of the market.

U.S. Stem Cell Therapy Market Statistics

Market Overview
Stem cell therapy is an ideal approach to eliminate generative deficiencies by replacing diseased cells. It replaces tissue or organs damaged by age, disease, or injuries. Stem cells have the ability to regenerate new tissues in the human body and, hence, are mostly used for therapeutic purposes in tissue regeneration and repair.

The U.S. stem cell therapy market has been witnessing rapid growth due to the increasing cases of osteoarthritis and musculoskeletal diseases. Stem cell therapy has the potential to heal wounds and is also under development for treating diseases like rheumatoid arthritis, Crohn's disease, and multiple sclerosis. In addition, the increasing funding by private and commercial sectors in stem cell therapy and innovations in technologies like 3D printing propel the market for U.S. stem cell therapy. The rising demand for personalized therapies that possess fewer side effects on the patients and the increasing use of CRISPR technology further contribute to market expansion.

Useful Links

Subscribe Now